Balyasny Asset Management LLC Royalty Pharma PLC Transaction History

Balyasny Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $719,333 - $801,942	27,445 Added 40.4%	95,382 $2.68 Million
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $1.78 Million - $2.13 Million	67,937 New	67,937 $1.84 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $11.4 Million - $12.7 Million	285,034 New	285,034 $11.5 Million
Q2 2022 Aug 15, 2022	SELL	$37.53 - $44.22 $7.43 Million - $8.75 Million	-197,889 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $7.41 Million - $8.4 Million	197,889 New	197,889 $7.71 Million

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.